The U.S. Meals and Drug Administration (FDA) has accepted PD-L1 IHC 22C3 pharmDx, Code SK006, as a companion diagnostic to assist establish sufferers with epithelial...
Minimal residual illness, or MRD, testing might have the potential to supply peace of thoughts to survivors of breast most cancers, as a survivor and...
The U.S. Meals and Drug Administration (FDA) has granted orphan drug designation to zenocutuzumab-zbco for the therapy of adults with superior unresectable...
The U.S. Meals and Drug Administration (FDA) has authorized an replace to the prescribing info for Yescarta (axicabtagene ciloleucel), eradicating earlier limitations...
The investigational oral remedy KTX-1001, often known as gintemetostat, is catching curiosity as a possible therapy for a subgroup of sufferers with...
Therapy with relacorilant plus Abraxane (nab-paclitaxel) could provide a broader choice for sufferers with platinum-resistant ovarian most cancers as a result of...
